Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1070529

High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions


Kopjar, Nevenka; Fuchs, Nino; Brčić Karačonji, Irena; Žunec, Suzana; Katić, Anja; Kozina, Goran; Lucić Vrdoljak, Ana
High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions // Clinical drug investigation, 40 (2020), 9; 775-787 doi:10.1007/s40261-020-00954-y (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1070529 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions
(High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions)

Autori
Kopjar, Nevenka ; Fuchs, Nino ; Brčić Karačonji, Irena ; Žunec, Suzana ; Katić, Anja ; Kozina, Goran ; Lucić Vrdoljak, Ana

Izvornik
Clinical drug investigation (1173-2563) 40 (2020), 9; 775-787

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Tetrahydrocannabinol ; irinotecan ; drug-drug interaction, illicit THC preparations

Sažetak
This review proposes the hypothesis that the effectiveness of irinotecan chemotherapy might be impaired by high doses of concomitantly administered Δ9-tetrahydrocannabinol (THC). The most important features shared by irinotecan and THC, which might represent sources of potentially harmful interactions are: first pass hepatic metabolism mediated by cytochrome P-450 (CYP) enzyme CYP3A4 ; glucuronidation mediated by uridine diphosphate glycosyltransferase (UGT) enzymes, isoforms 1A1 and 1A9 ; transport of parent compounds and their metabolites via canalicular ATP-binding cassette (ABC) transporters ABCB1 and ABCG2 ; enterohepatic recirculation of both parent compounds which leads to an extended duration of their pharmacological effects ; possible competition for binding to albumin ; butyrylcholinesterase (BChE) inhibition by THC which might impair the conversion of parent irinotecan into the SN-38 metabolite ; mutual effects on mitochondrial dysfunction and induction of oxidative stress ; potentiation of hepatotoxicity ; potentiation of genotoxicity and cytogenetic effects leading to genome instability ; possible neurotoxicity ; and effects on bilirubin. The controversies associated with the use of highly concentrated THC preparations with irinotecan chemotherapy are also discussed. Despite all of the limitations, the body of evidence provided here could be considered relevant for human risk assessments and calls for concern in cases when irinotecan chemotherapy is accompanied by preparations rich in THC.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Farmacija



POVEZANOST RADA


Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Klinički bolnički centar Zagreb,
Sveučilište Sjever, Koprivnica

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Kopjar, Nevenka; Fuchs, Nino; Brčić Karačonji, Irena; Žunec, Suzana; Katić, Anja; Kozina, Goran; Lucić Vrdoljak, Ana
High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions // Clinical drug investigation, 40 (2020), 9; 775-787 doi:10.1007/s40261-020-00954-y (međunarodna recenzija, članak, znanstveni)
Kopjar, N., Fuchs, N., Brčić Karačonji, I., Žunec, S., Katić, A., Kozina, G. & Lucić Vrdoljak, A. (2020) High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions. Clinical drug investigation, 40 (9), 775-787 doi:10.1007/s40261-020-00954-y.
@article{article, year = {2020}, pages = {775-787}, DOI = {10.1007/s40261-020-00954-y}, keywords = {Tetrahydrocannabinol, irinotecan, drug-drug interaction, illicit THC preparations}, journal = {Clinical drug investigation}, doi = {10.1007/s40261-020-00954-y}, volume = {40}, number = {9}, issn = {1173-2563}, title = {High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions}, keyword = {Tetrahydrocannabinol, irinotecan, drug-drug interaction, illicit THC preparations} }
@article{article, year = {2020}, pages = {775-787}, DOI = {10.1007/s40261-020-00954-y}, keywords = {Tetrahydrocannabinol, irinotecan, drug-drug interaction, illicit THC preparations}, journal = {Clinical drug investigation}, doi = {10.1007/s40261-020-00954-y}, volume = {40}, number = {9}, issn = {1173-2563}, title = {High doses of Δ9-tetrahydrocannabinol might impair irinotecan chemotherapy: A review of potentially harmful interactions}, keyword = {Tetrahydrocannabinol, irinotecan, drug-drug interaction, illicit THC preparations} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font